The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of the effect of perindopril on hand foot syndrome (HFSR) incidence and severity in patients receiving regorafenib with refractory metastatic colorectal carcinoma (mCRC).
 
Barbara L. Melosky
Consulting or Advisory Role - Amgen; Bayer; Lilly; Roche
 
Howard John Lim
Stock and Other Ownership Interests - Peregrine Pharmaceuticals
Honoraria - Ipsen; LEO Pharma; Lilly/ImClone; Merck; Roche Canada
 
Janine Davies
No Relationships to Disclose
 
Sharlene Gill
Honoraria - Celgene; Lilly
Consulting or Advisory Role - Celgene; Lilly; Shire; Taiho Pharmaceutical
Research Funding - Celgene
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Maria Ho
No Relationships to Disclose
 
Solomon A. Vandt
No Relationships to Disclose
 
Daniel John Renouf
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Celgene; Shire
Research Funding - Bayer